SHUKLA SANJAY (President and CEO) purchased 464.8% of their position (6K shares) of ATYR PHARMA INC on the open market
Open‑market purchase worth $25.6K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/23/2020ACC: 0001209191-20-038463
Officer· President and CEO
Since Feb 2019
+6K
Net shares
Net buyer
$25.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
6K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6K
Price / share
$4.27
Trade value
$25.62K
% of position
464.8%
6/19/2020
1.29K→7.29K
Total
Net shares
+6K
Net value
$25.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/19/2020 | P · Purchase | +6K | $4.27 | $25.62K | 464.8% | 1.29K | 7.29K |
| Total | +6K | $25.62K | ||||||
Derivative Transactions0
No derivative transactions reported